| Oral melanosis after tyrosine kinase inhibition with Imatinib for chronic myelogenous leukemia: Report of a case and review of the literature. | |
| | |
MedLine Citation:
|
PMID: 21635826 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Dermatologic manifestations from therapy with imatinib are well known and frequently include hypopigmentation, and less commonly, hyperpigmentation. There have been few reports of oral hyperpigmentation. We present a case of palatal melanosis related to imatinib therapy for chronic myelogenous leukemia. This case is reported to add to the sparse literature concerning mucosal reactions related to this medication. |
| | |
Authors:
|
Michelle Wong; Shachar Sade; Melanie Gilbert; Hagen B E Klieb |
Related Documents
:
|
20688296 - Plesiomonas shigelloides sepsis and meningoencephalitis in a surviving neonate. 1254706 - Meningitis due to aeromonas hydrophila. 14620646 - Eosinophilic meningitis: a case series report and review of the literature. 3826896 - A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial ... 16636626 - Atypical traumatic craniocervical junction focal spinal subdural hematoma. 22445006 - Quality assurance peer review chart rounds in 2011: a survey of academic institutions i... |
Publication Detail:
|
Type: Journal Article Date: 2011-05-15 |
Journal Detail:
|
Title: Dermatology online journal Volume: 17 ISSN: 1087-2108 ISO Abbreviation: Dermatol. Online J. Publication Date: 2011 |
Date Detail:
|
Created Date: 2011-06-03 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9610776 Medline TA: Dermatol Online J Country: United States |
Other Details:
|
Languages: eng Pagination: 4 Citation Subset: IM |
Affiliation:
|
University of Toronto, Sunnybrook Health Sciences Center, Department of Dentistry. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Generalized linear porokeratosis: A rare entity with excellent response to acitretin.
Next Document: Cutaneous fusariosis developing in a post-irradiation site.